West Paces Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-29
Closed -$1.92K 586
2024
Q1
$1.92K Hold
29
﹤0.01% 461
2023
Q4
$1.65K Buy
+29
New +$1.52K ﹤0.01% 475

Other funds holding LMAT

West Paces Advisors's LMAT Position: Q2 2024 in Review

West Paces Advisors sold out of LeMaitre Vascular (LMAT) in Q2 2024, closing a stake of 29 shares — an estimated $1.92K sold.

West Paces Advisors first reported a position in LMAT in Q4 2023 and held it in 2 quarters. The position peaked at $1.92K in Q1 2024. 261 funds tracked by Wall St. Rank hold LMAT as of Q2 2024.

  • West Paces Advisors reported no remaining LeMaitre Vascular position as of Q2 2024 after selling out during the quarter.
  • West Paces Advisors sold 29 LeMaitre Vascular shares in Q2 2024, an estimated $1.92K.
  • West Paces Advisors first reported a position in LeMaitre Vascular in Q4 2023 and held it in 2 quarters.
  • West Paces Advisors's LeMaitre Vascular position peaked at $1.92K in Q1 2024.
  • 261 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2024.

Based on West Paces Advisors's 13F filing for Q2 2024, filed 17 Jul 2024.